FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government 
Re-authorization of the Pandemic and All-Hazards Preparedness Act 
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government 
Re-authorization of the Pandemic and All-Hazards Preparedness Act 
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government 
Re-authorization of the Pandemic and All-Hazards Preparedness Act 
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants
DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
EMERGENT BIOSOLUTIONS INC.
1455 Pennsylvania Avenue, NW, SUITE 1225, Washington, DC, 20004, US
CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY